ALLMedicine™ 5'-nucleotidase Center
Research & Reviews 228 results
Oncogene King RJ, Shukla SK et. al.
Jan 11th, 2022 - Metabolic alterations regulate cancer aggressiveness and immune responses. Given the poor response of pancreatic ductal adenocarcinoma (PDAC) to conventional immunotherapies, we investigated the link between metabolic alterations and immunosuppres...
Journal of Neurosurgery; Zhang Y, Wang X et. al.
Sep 4th, 2021 - Vagus nerve stimulation (VNS) is an alternative treatment option for individuals with refractory epilepsy, with nearly 40% of patients showing no benefit after VNS and only 6%-8% achieving seizure freedom. It is presently unclear why some patients...
Cancer Letters; Ploeg EM, Ke X et. al.
Sep 1st, 2021 - Tumor-derived extracellular vesicles (EVs) carry potent immunosuppressive factors that affect the antitumor activities of immune cells. A significant part of the immunoinhibitory activity of EVs is attributable to CD73, a GPI-anchored ecto-5'-nucl...
Journal of Clinical Neuromuscular Disease; Mavroudis I, Knights M et. al.
Aug 26th, 2021 - Sporadic inclusion body myositis (IBM) is an acquired muscle disease and the most common idiopathic inflammatory myopathy over the age of 50. It is characterized by male predominance, with a prevalence rate between 1 and 71 cases per million, reac...
Cancer Letters; Yu X, Liu W et. al.
Jul 25th, 2021 - CD73, a cell surface-localized ecto-5'-nucleotidase, is the major enzymatic source of extracellular adenosine. Canonically, it plays multiple roles in cancer-related processes via its metabolite. As a druggable target, clinical trials targeting CD...
Clinicaltrials.gov 1 results
Oct 1st, 2009 - Rationale: Statins form a class of drugs that is widely prescribed for hypercholesterolaemia, specifically to reduce the risk on atherosclerosis by lowering LDL-cholesterol. Next to the effect for which the drug was originally developed, it became...